EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Therapeutic Targeting in Ovarian Cancer: Nano-Enhanced CRISPR/Cas9 Gene Editing and Drug Combination Therapy

Hong-Kook Kim iD, Heedon Cheong iD, Moo-Yeon Kim, Hyo-Eon Jin iD

International Journal of Nanomedicine · 2025

DOI: 10.2147/ijn.s507688 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2025. Verfasst von Hong-Kook Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: AI-Super Convergence KIURI Translational Research Center, Ajou University, Suwon, 16499, Republic of Korea. Hauptthemen laut MEDLINE: Ovarian Neoplasms, CRISPR-Cas Systems, Gene Editing, Genetic Therapy. Die Arbeit wurde bisher 23-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsCRISPR-Cas SystemsGene EditingGenetic TherapyHumansFemaleNanoparticlesAnimalsDrug Delivery SystemsDrug Resistance, NeoplasmMolecular Targeted TherapyAntineoplastic Agents

Stichwörter der Autor:innen

CRISRP/Cas9anti-cancer drugsnano-based deliveryovarian cancertherapeutic genes

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • AI-Super Convergence KIURI Translational Research Center, Ajou University, Suwon, 16499, Republic of Korea.
  • Research Institute of Pharmaceutical Science and Technology, Ajou University, Suwon, 16499, Republic of Korea.
  • Department of Pharmacy, Ajou University, Suwon, 16499, Republic of Korea.

ORCID-Profile: Hong-Kook Kim, Heedon Cheong, Hyo-Eon Jin

Zitieren

APA

Kim, H. K., Cheong, H., Kim, M. Y., & Jin, H. E. (2025). Therapeutic Targeting in Ovarian Cancer: Nano-Enhanced CRISPR/Cas9 Gene Editing and Drug Combination Therapy. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s507688

Vancouver

Kim HK, Cheong H, Kim MY, Jin HE. Therapeutic Targeting in Ovarian Cancer: Nano-Enhanced CRISPR/Cas9 Gene Editing and Drug Combination Therapy. International Journal of Nanomedicine. 2025. doi:10.2147/ijn.s507688

BibTeX
@article{Kim2025,
  author = {Kim, Hong-Kook and Cheong, Heedon and Kim, Moo-Yeon and Jin, Hyo-Eon},
  title = {Therapeutic Targeting in Ovarian Cancer: Nano-Enhanced CRISPR/Cas9 Gene Editing and Drug Combination Therapy},
  journal = {International Journal of Nanomedicine},
  year = {2025},
  doi = {10.2147/ijn.s507688}
}
Kostenlos starten →